Brief: Absci And Precisionlife Announce Strategic Research And Development Partnership To Jointly Develop Ai-Enabled Drug Pipeline
Dec 20 (Reuters) - Absci Corp ABSI.O :
* ABSCI AND PRECISIONLIFE ANNOUNCE STRATEGIC RESEARCH AND
DEVELOPMENT PARTNERSHIP TO JOINTLY DEVELOP AI-ENABLED DRUG
PIPELINE
Source text for Eikon: ID:nGNX7mvwMR
Further company coverage: ABSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AbSci
See all newsAbsci Corp reports results for the quarter ended September 30 - Earnings Summary
Brief: Absci Corp Files For Mixed Shelf Size Not Disclosed - SEC Filing
Absci Q3 revenue misses estimates, net loss widens on R&D spends
Focus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave